A monthly injection changed the economics of Indivior. The harder question is whether changing the treatment calendar can help more people stay in care.
Ophelia is a New York-based telehealth company making evidence-based opioid use disorder (OUD) treatment available from home. It connects people to licensed clinicians for medication-assisted treatment (buprenorphine/Suboxone), with video visits, on-demand messaging, and care coordination, deliberately removing the friction and stigma of traditional rehab. Founded in 2019 by Zack Gray after he lost a loved one to an overdose, Ophelia focuses heavily on Medicaid and rural populations and has raised roughly $68 million, including a $50M Series B led by Tiger Global in 2021.